Justin Walsh
Stock Analyst at Jones Trading
(3.94)
# 617
Out of 5,139 analysts
38
Total ratings
40.54%
Success rate
18.19%
Average return
Main Sectors:
Stocks Rated by Justin Walsh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATAI AtaiBeckley | Initiates: Buy | $16 | $3.64 | +339.56% | 1 | Dec 23, 2025 | |
| PRAX Praxis Precision Medicines | Initiates: Buy | $83 | $317.25 | -73.84% | 1 | Sep 18, 2025 | |
| LNTH Lantheus Holdings | Maintains: Buy | $109 → $84 | $64.25 | +30.74% | 10 | Sep 16, 2025 | |
| VNRX VolitionRx | Initiates: Buy | $3 | $0.29 | +923.19% | 1 | Jun 10, 2025 | |
| BLRX BioLineRx | Upgrades: Buy | $12 | $2.88 | +316.67% | 3 | May 30, 2025 | |
| CLNN Clene | Initiates: Buy | $30 | $5.05 | +494.06% | 1 | Apr 23, 2025 | |
| MNPR Monopar Therapeutics | Downgrades: Hold | n/a | $70.00 | - | 1 | Apr 2, 2025 | |
| SER Serina Therapeutics | Initiates: Buy | $11 | $3.10 | +254.84% | 1 | Mar 11, 2025 | |
| ANRO Alto Neuroscience | Initiates: Buy | $18 | $17.17 | +4.83% | 1 | Dec 16, 2024 | |
| RAPP Rapport Therapeutics | Initiates: Buy | $42 | $26.81 | +56.66% | 1 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $22 | $2.33 | +844.21% | 2 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $5.53 | +189.59% | 1 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $5.83 | +243.05% | 1 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $4 | $0.70 | +469.80% | 4 | Sep 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $3.98 | +402.51% | 1 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $360 | $15.75 | +2,185.71% | 2 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $440 | $1.16 | +37,831.03% | 1 | Feb 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $0.29 | +25,959.76% | 1 | Oct 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $20 | $47.90 | -58.25% | 1 | May 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $440 → $200 | $1.00 | +19,990.41% | 2 | Apr 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $5.70 | +75.44% | 1 | Jan 19, 2022 |
AtaiBeckley
Dec 23, 2025
Initiates: Buy
Price Target: $16
Current: $3.64
Upside: +339.56%
Praxis Precision Medicines
Sep 18, 2025
Initiates: Buy
Price Target: $83
Current: $317.25
Upside: -73.84%
Lantheus Holdings
Sep 16, 2025
Maintains: Buy
Price Target: $109 → $84
Current: $64.25
Upside: +30.74%
VolitionRx
Jun 10, 2025
Initiates: Buy
Price Target: $3
Current: $0.29
Upside: +923.19%
BioLineRx
May 30, 2025
Upgrades: Buy
Price Target: $12
Current: $2.88
Upside: +316.67%
Clene
Apr 23, 2025
Initiates: Buy
Price Target: $30
Current: $5.05
Upside: +494.06%
Monopar Therapeutics
Apr 2, 2025
Downgrades: Hold
Price Target: n/a
Current: $70.00
Upside: -
Serina Therapeutics
Mar 11, 2025
Initiates: Buy
Price Target: $11
Current: $3.10
Upside: +254.84%
Alto Neuroscience
Dec 16, 2024
Initiates: Buy
Price Target: $18
Current: $17.17
Upside: +4.83%
Rapport Therapeutics
Oct 18, 2024
Initiates: Buy
Price Target: $42
Current: $26.81
Upside: +56.66%
May 16, 2024
Maintains: Buy
Price Target: $15 → $22
Current: $2.33
Upside: +844.21%
May 10, 2024
Initiates: Buy
Price Target: $16
Current: $5.53
Upside: +189.59%
Apr 17, 2024
Initiates: Buy
Price Target: $20
Current: $5.83
Upside: +243.05%
Sep 7, 2023
Reinstates: Buy
Price Target: $4
Current: $0.70
Upside: +469.80%
Sep 6, 2023
Initiates: Buy
Price Target: $20
Current: $3.98
Upside: +402.51%
May 16, 2023
Initiates: Buy
Price Target: $360
Current: $15.75
Upside: +2,185.71%
Feb 10, 2023
Initiates: Buy
Price Target: $440
Current: $1.16
Upside: +37,831.03%
Oct 7, 2022
Initiates: Buy
Price Target: $75
Current: $0.29
Upside: +25,959.76%
May 20, 2022
Maintains: Buy
Price Target: $17 → $20
Current: $47.90
Upside: -58.25%
Apr 5, 2022
Maintains: Buy
Price Target: $440 → $200
Current: $1.00
Upside: +19,990.41%
Jan 19, 2022
Initiates: Buy
Price Target: $10
Current: $5.70
Upside: +75.44%